The Use of Food and Drug Administration Approved Medications for Unlabeled (Off-Label) Uses

作者: Abel Torres

DOI: 10.1001/ARCHDERM.1994.01690010036003

关键词:

摘要: Physicians increasingly use Food and Drug Administration (FDA)-approved drugs (medication) for unlabeled (off-label) indications. The ethical legal implications of these actions are not always clear. In this article, I examine the common law federal statutory regulations concerning issue also explore some financial issues involved. BACKGROUND One prescribes a drug in hope that medication will benefit person to whom it is given. Yet, every has potential cause effects on body can be beneficial or adverse. 1 Adverse reactions range seriousness from relatively mild fatal. estimate showed adverse responsible 1.0% 3.5% admissions medical wards. 2 government 130 000 US hospital— based deaths per year were caused by reactions. 3 These occur with proper (idiosyncratic)

参考文章(5)
Dale H. Cowan, Eva Bertsch, Innovative therapy. The responsibility of hospitals. Journal of Legal Medicine. ,vol. 5, pp. 219- 251 ,(1984) , 10.1080/01947648409513409
Samuel Shapiro, Fatal Drug Reactions Among Medical Inpatients JAMA: The Journal of the American Medical Association. ,vol. 216, pp. 467- 472 ,(1971) , 10.1001/JAMA.1971.03180290043005
Robert Temple, Legal Implications of the Package Insert Medical Clinics of North America. ,vol. 58, pp. 1151- 1159 ,(1974) , 10.1016/S0025-7125(16)32112-5
Tom L Beauchamp, James F Childress, Principles of biomedical ethics Published in <b>1983</b> in New York (N.Y.) by Oxford university press. ,(1983)